H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 14 670 KRW 1.24% Market Closed
Market Cap: 584.1B KRW
Have any thoughts about
Hyundai Bioscience Co Ltd?
Write Note

Hyundai Bioscience Co Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hyundai Bioscience Co Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
H
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Short-Term Investments
â‚©0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Short-Term Investments
â‚©617.9B
CAGR 3-Years
5%
CAGR 5-Years
73%
CAGR 10-Years
13%
Amorepacific Group
KRX:002790
Short-Term Investments
â‚©1.1T
CAGR 3-Years
4%
CAGR 5-Years
55%
CAGR 10-Years
5%
Cosmax Inc
KRX:192820
Short-Term Investments
â‚©29.2B
CAGR 3-Years
118%
CAGR 5-Years
34%
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Short-Term Investments
â‚©384.7B
CAGR 3-Years
67%
CAGR 5-Years
56%
CAGR 10-Years
37%
Kolmar Korea Co Ltd
KRX:161890
Short-Term Investments
â‚©47.8B
CAGR 3-Years
-45%
CAGR 5-Years
-21%
CAGR 10-Years
-4%
No Stocks Found

Hyundai Bioscience Co Ltd
Glance View

Market Cap
584.1B KRW
Industry
Consumer products

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Intrinsic Value
501.94 KRW
Overvaluation 97%
Intrinsic Value
Price
H

See Also

What is Hyundai Bioscience Co Ltd's Short-Term Investments?
Short-Term Investments
0 KRW

Based on the financial report for Jun 30, 2024, Hyundai Bioscience Co Ltd's Short-Term Investments amounts to 0 KRW.

Back to Top